Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Cantor Fitzgerald
Farmers Insurance
Daiichi Sankyo
Chubb
US Department of Justice
Covington
Johnson and Johnson
Medtronic
QuintilesIMS

Generated: August 21, 2017

DrugPatentWatch Database Preview

ALEVE Drug Profile

« Back to Dashboard

Which patents cover Aleve, and when can generic versions of Aleve launch?

Aleve is a drug marketed by Bayer and Bayer Hlthcare and is included in three NDAs.

The generic ingredient in ALEVE is naproxen sodium; pseudoephedrine hydrochloride. There are forty-two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the naproxen sodium; pseudoephedrine hydrochloride profile page.

Summary for Tradename: ALEVE

Patents:0
Applicants:2
NDAs:3
Suppliers / Packagers: see list9
Bulk Api Vendors: see list133
Clinical Trials: see list14
Patent Applications: see list4,448
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ALEVE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer
ALEVE
naproxen sodium
TABLET;ORAL020204-002Jan 11, 1994OTCYesYes► Subscribe► Subscribe► Subscribe
Bayer Hlthcare
ALEVE PM
diphenhydramine hydrochloride; naproxen sodium
TABLET;ORAL205352-001Jan 17, 2014OTCYesYes► Subscribe► Subscribe► Subscribe
Bayer
ALEVE-D SINUS & COLD
naproxen sodium; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL021076-001Nov 29, 1999OTCYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Medtronic
Mallinckrodt
Fuji
Baxter
Citi
Express Scripts
Harvard Business School
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot